Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Implantation of Iakymenko keratoprosthesis in patients with severe ocular injury.

Pan HW, Iakymenko S, Xu JT, Hou GH, Sun BJ, Zheng AN.

Int J Ophthalmol. 2012;5(2):167-71. doi: 10.3980/j.issn.2222-3959.2012.02.10. Epub 2012 Apr 18.

PMID:
22762043
[PubMed]
Free PMC Article
2.

Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.

Greiner MA, Li JY, Mannis MJ.

Ophthalmology. 2011 Aug;118(8):1543-50. doi: 10.1016/j.ophtha.2010.12.032. Epub 2011 Mar 12.

PMID:
21397948
[PubMed - indexed for MEDLINE]
3.

Keratoprosthesis surgery for end-stage corneal blindness in asian eyes.

Tan DT, Tay AB, Theng JT, Lye KW, Parthasarathy A, Por YM, Chan LL, Liu C.

Ophthalmology. 2008 Mar;115(3):503-510.e3. doi: 10.1016/j.ophtha.2007.04.065.

PMID:
18319104
[PubMed - indexed for MEDLINE]
4.

Visual rehabilitation with keratoprosthesis after tenonplasty as the primary globe-saving procedure for severe ocular chemical injuries.

Iyer G, Srinivasan B, Agarwal S, Barbhaya R.

Graefes Arch Clin Exp Ophthalmol. 2012 Dec;250(12):1787-93. doi: 10.1007/s00417-012-2030-8. Epub 2012 May 1.

PMID:
22546999
[PubMed - indexed for MEDLINE]
5.

Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases.

Iakymenko S.

Int J Ophthalmol. 2013 Jun 18;6(3):375-80. doi: 10.3980/j.issn.2222-3959.2013.03.22. Print 2013.

PMID:
23826536
[PubMed]
Free PMC Article
6.

The Boston type I keratoprosthesis: improving outcomes and expanding indications.

Aldave AJ, Kamal KM, Vo RC, Yu F.

Ophthalmology. 2009 Apr;116(4):640-51. doi: 10.1016/j.ophtha.2008.12.058. Epub 2009 Feb 25.

PMID:
19243830
[PubMed - indexed for MEDLINE]
7.

[Clinical application of keratoprosthesis for corneal opacity unsuitable for keratoplasty].

Huang YF, Wang LQ, Wang FX.

Zhonghua Yan Ke Za Zhi. 2003 Oct;39(10):578-81. Chinese.

PMID:
14766069
[PubMed - indexed for MEDLINE]
8.

[Preliminary study of Boston keratoprosthesis in treatment of severe late stage ocular chemical burns].

Chen JQ, Zhai JJ, Gu JJ, Shao YF, Liu YM, Yuan J, Zhou SY.

Zhonghua Yan Ke Za Zhi. 2012 Jun;48(6):537-41. Chinese.

PMID:
22943810
[PubMed - indexed for MEDLINE]
9.

Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK.

Liu C, Okera S, Tandon R, Herold J, Hull C, Thorp S.

Br J Ophthalmol. 2008 Sep;92(9):1211-7. doi: 10.1136/bjo.2007.130567. Epub 2008 May 29.

PMID:
18511541
[PubMed - indexed for MEDLINE]
10.

Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.

Kim MK, Lee SM, Lee JL, Chung TY, Kim YH, Wee WR, Lee JH.

Cornea. 2007 Jun;26(5):546-51.

PMID:
17525649
[PubMed - indexed for MEDLINE]
11.

The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.

Pujari S, Siddique SS, Dohlman CH, Chodosh J.

Cornea. 2011 Dec;30(12):1298-303. doi: 10.1097/ICO.0b013e318215207c.

PMID:
21963861
[PubMed - indexed for MEDLINE]
12.

Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.

Kang JJ, de la Cruz J, Cortina MS.

Cornea. 2012 Dec;31(12):1436-40. doi: 10.1097/ICO.0b013e31823f7765.

PMID:
22367042
[PubMed - indexed for MEDLINE]
13.

[Clinical application of keratoprosthesis for corneal opacity caused by chemical burn unsuitable for keratoplasty].

Huang YF, Wang DJ, Wang LQ, Zhang H, Ma X.

Zhonghua Yan Ke Za Zhi. 2007 Apr;43(4):297-302. Chinese.

PMID:
17605923
[PubMed - indexed for MEDLINE]
14.

International results with the Boston type I keratoprosthesis.

Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, Kharashi SA, Jindan MA, Tandon R, Mascarenhas J, Malyugin B, Padilla MD, Maskati Q, Agarwala N, Hutauruk J, Sharma M, Yu F.

Ophthalmology. 2012 Aug;119(8):1530-8. doi: 10.1016/j.ophtha.2012.02.015. Epub 2012 Apr 17.

PMID:
22512986
[PubMed - indexed for MEDLINE]
15.

Pediatric keratoprosthesis.

Aquavella JV, Gearinger MD, Akpek EK, McCormick GJ.

Ophthalmology. 2007 May;114(5):989-94.

PMID:
17467531
[PubMed - indexed for MEDLINE]
16.

Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.

Cade F, Grosskreutz CL, Tauber A, Dohlman CH.

Cornea. 2011 Dec;30(12):1322-7. doi: 10.1097/ICO.0b013e31821eead6.

PMID:
22001817
[PubMed - indexed for MEDLINE]
17.

The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.

Sejpal K, Yu F, Aldave AJ.

Cornea. 2011 Nov;30(11):1187-94. doi: 10.1097/ICO.0b013e3182114467.

PMID:
21885964
[PubMed - indexed for MEDLINE]
18.

Results from the multicenter Boston Type 1 Keratoprosthesis Study.

Zerbe BL, Belin MW, Ciolino JB; Boston Type 1 Keratoprosthesis Study Group.

Ophthalmology. 2006 Oct;113(10):1779.e1-7. Epub 2006 Jul 26.

PMID:
16872678
[PubMed - indexed for MEDLINE]
19.

Boston type 1 keratoprosthesis: the university of california davis experience.

Bradley JC, Hernandez EG, Schwab IR, Mannis MJ.

Cornea. 2009 Apr;28(3):321-7. doi: 10.1097/ICO.0b013e31818b8bfa.

PMID:
19387235
[PubMed - indexed for MEDLINE]
20.

AlphaCor keratoprosthesis: postoperative development of six patients.

Holak SA, Holak HM, Bleckmann H.

Graefes Arch Clin Exp Ophthalmol. 2009 Apr;247(4):535-9. doi: 10.1007/s00417-008-0964-7. Epub 2008 Oct 22.

PMID:
18941767
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk